News

As per the agreement, Actavis has exclusive rights to commercialize and further develop MoxDuo IR for the US market. Actavis will assume all costs for product launch as

The study compared safety and efficacy of three dose levels of PH-10 (0.002%, 0.005% and 0.01% Rose Bengal) against vehicle. The Phase II trial had randomised ninety-nine patients

The company introduces a portfolio of five Mosaic Multiplex lung cancer kits for use in tissue analysis of suspected lung cancer patients. Mosaic Multiplex kits will allow testing

The transaction is expected to close at the end of March 2012. KCR will be combined with inVentiv’s existing functional service provider (FSP) and staffing businesses within the

The study will provide insights to exploit the nuclear and/or mitochondrial pro-apoptotic function by Kevetrin in combination with other multikinase inhibitors in treatment of these malignancies, Cellceutix said.

The once-daily, long-acting beta2-agonist (LABA) approved in the US is an inhaled, steroid-free chronic obstructive pulmonary disease (COPD) treatment. The product is indicated for the long-term maintenance bronchodilator

The grant, which provides $1.5m in funding over two years, was based on the successful completion of a Phase I SBIR award. Avaxia founder and CEO Barbara Fox

The Wool Packaging Company has received a grant from the Technology Strategy Board to focus on a specialised pharmaceuticals version of its Woolcool insulated packaging to protect temperature

The closure of the plant in Fawdon, near Newcastle upon Tyne, will be associated with the loss of 450 jobs. The closure is being considered in the context